sr141716 has been researched along with Hypersensitivity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akdis, C; Akdis, M; Angelina, A; López-Abente, J; Martín-Fontecha, M; Nombela, I; Palomares, O; Pérez-Diego, M; Rückert, B | 1 |
| Conrad, DH; Lichtman, AH; O'Neal, ST; Schlosburg, JE | 1 |
2 other study(ies) available for sr141716 and Hypersensitivity
| Article | Year |
|---|---|
Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming.
Topics: Anaphylaxis; Animals; Anti-Inflammatory Agents; Autophagy; Cannabinoids; Cells, Cultured; Cellular Reprogramming; Coculture Techniques; Dendritic Cells; Humans; Hypersensitivity; Immune Tolerance; Indoles; Mice; Oxidative Phosphorylation; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Signal Transduction; T-Lymphocytes, Regulatory; Th1-Th2 Balance | 2022 |
CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Female; Histamine H1 Antagonists; Hypersensitivity; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Spinal; Injections, Subcutaneous; Loratadine; Male; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; Pain; Piperidines; Pruritus; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant | 2011 |